Bachelorette alum Ali Fedotowsky-Manno shared an update on her dog's brain tumor several months after her husband, Kevin ...

Exelixis (NASDAQ:EXEL) said on Wednesday that the U.S. FDA has approved cabozantinib for patients 12 years of age and older ...

Exelixis (EXEL) wins FDA approval for Cabometyx for advanced pancreatic and extra pancreatic neuroendocrine tumors in ...

Katie Thurston’s husband Jeff Arcuri explained why he wanted to push their wedding plans up and marry the Bachelor Nation ...

Neuroendocrine tumors that start in the pancreas tend to be more aggressive and have a poor prognosis.

Responding to the progress of its obesity pipeline, the Chinese biotech is stepping up its investment in metabolic disease ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

Theratechnologies Inc.’s THTX share price has surged by 28.57%, which has investors questioning if this is right time to sell ...

Bekah Kooy, 38, was convinced she had food poisoning when she felt nauseated and experienced stomach pain following lunch one ...

Cabozantinib significantly improved progression free survival in patients with pNET and epNET compared with placebo.

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.